Literature DB >> 27831658

Postmenopausal vulvovaginal atrophy (VVA) is positively improved by topical hyaluronic acid application. A prospective, observational study.

M Origoni1, C Cimmino, G Carminati, E Iachini, C Stefani, S Girardelli, S Salvatore, M Candiani.   

Abstract

OBJECTIVE: To evaluate the effectiveness of a topical vaginal preparation containing hyaluronic acid in controlling signs and symptoms correlated with postmenopausal vulvovaginal atrophy (VVA). PATIENTS AND METHODS: A prospective, observational study has been performed at the Obstetrics and Gynecology Department of the Vita Salute San Raffaele University of Milan, Italy. Forty-six (46) consecutive postmenopausal women complaining of genital discomfort due to postmenopausal estrogen lack have been enrolled. All patients have been investigated by the use of the Vaginal Health Index (VHI) and of a Visual Analogic Scale (VAS) of symptoms at baseline and one month after the end of the study. The treatment protocol consisted of the administration of a hyaluronic acid-based liquid preparation for vaginal use (Justgin®, Just Pharma, Rome, Italy) three times a week, for a total of 8 weeks. Statistical analysis of VHI and VAS scores has been performed by the use of the Wilcoxon signed-rank test for repeated values, assuming a p-value < 0.05 as significant.
RESULTS: Both Vaginal Health Index (VHI) and Visual Analogic Scale (VAS) of genital symptoms showed statistically significant (p < 0.0001) improvements at the end of the study protocol. Patients' degree of satisfaction at the end of treatment was reported as high.
CONCLUSIONS: Conventional treatment of the postmenopausal syndrome, either in terms of systemic and genital symptoms, is based on hormonal replacement therapy (HRT). The limitations to this approach are represented by the need to discontinue the treatment after some years and the contraindications that some women present about the estrogens. For these reasons, alternative approaches have been recently investigated and indicate promising perspectives. Hyaluronic acid topical approach with a liquid preparation for vaginal use (Justgin®, Just Pharma, Roma, Italy) to control signs and symptoms of vulvovaginal atrophy (VVA) in postmenopausal women demonstrated significant effectiveness both in terms of objective and subjective improvement.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27831658

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

Review 1.  Materials Selection for the Injection into Vaginal Wall for Treatment of Vaginal Atrophy.

Authors:  Zhifang Zheng; Junfeiyang Yin; Biao Cheng; Wenhua Huang
Journal:  Aesthetic Plast Surg       Date:  2021-03-01       Impact factor: 2.326

Review 2.  Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause.

Authors:  Risa Kagan; Susan Kellogg-Spadt; Sharon J Parish
Journal:  Drugs Aging       Date:  2019-10       Impact factor: 3.923

3.  Non-inferiority study of the efficacy of two hyaluronic acid products in post-extraction sockets of impacted third molars.

Authors:  Hyunwoo Yang; Junghun Kim; Jihong Kim; Dongwook Kim; Hyung Jun Kim
Journal:  Maxillofac Plast Reconstr Surg       Date:  2020-12-09

Review 4.  Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors?

Authors:  Rossella E Nappi; Silvia Martella; Francesca Albani; Chiara Cassani; Ellis Martini; Fabio Landoni
Journal:  Healthcare (Basel)       Date:  2022-08-13

5.  Local treatment with a polycarbophil-based cream in postmenopausal women with genitourinary syndrome of menopause.

Authors:  Tipatai Yodplob; Kun Sirisopana; Mutita Jongwannasiri; Pokket Sirisreetreerux; Wit Viseshsindh; Wachira Kochakarn
Journal:  Int Urogynecol J       Date:  2020-03-23       Impact factor: 2.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.